Researchers pairing antiviral, chemotherapy drugs to fight leukemia

Researchers from the University of Montreal and a Canadian pharmaceutical company are launching a clinical trial that aims to treat a form of leukemia by combining a common antiviral drug and standard chemotherapy drugs. After promising results from a 2009 trial that treated 11 acute myeloid leukemia patients with the common antiviral drug Ribavirin, Dr. Katherine Borden was preparing to start a second clinical trial that combined Ribavirin with low doses of standard chemotherapy drugs. Read more here.